Zhejiang Orient Gene Biotech Co.,Ltd. (688298.SH) Secures Medical Device Registration Certificates

Stock News
May 26

Zhejiang Orient Gene Biotech Co.,Ltd. (688298.SH) has announced that the company and its wholly-owned subsidiary, Healgen Scientific LLC, recently obtained registration certificates for several medical device products. Additionally, the hantavirus antibody detection reagent from its controlled subsidiary, Beijing Emerging Sihuan Biotechnology Co., Ltd., has completed its renewal certification process. Specifically, the Hantavirus IgM Antibody Test Kit (Colloidal Gold Method) from Beijing Emerging Sihuan Biotechnology Co., Ltd. has finished its renewal formalities. The company's Class III medical device registration certificate issued by China's NMPA now remains valid until 2031. This product is primarily used for early differential diagnosis of disease antibodies and can assist in the rapid identification of hantavirus infections. The acquisition of certificates for the company's other products in countries and regions such as Ethiopia, Saudi Arabia, and Brazil further enriches and enhances the layout of its time-resolved fluorescence immunochromatographic products in these markets. This development also expands the sales regions for related products, contributing to the overall expansion of the time-resolved fluorescence immunochromatographic product market both domestically and internationally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10